nyumets.org

What It Is

NYUMets is an open data science research project led by NYU Grossman School of Medicine and the NYU Center for Data Science. Its goal is to advance understanding of the dynamic evolution of metastatic cancer through open, longitudinal, real-world metastatic cancer data and software tools. It is not a consumer-facing chat-style AI product, but rather research infrastructure, with a particular focus on brain metastases, Gamma Knife radiosurgery, MRI imaging, medication, follow-up, and outcomes data.

Core Capabilities

Based on the main content, NYUMets’ AI value lies less in providing ready-made models and more in offering data assets and tools that can support AI modeling. NYUMets_Brain includes de-identified clinical data, divided into time-series data, patient-level data, Gamma Knife treatment details, and imaging metadata. Its fields cover medication changes, imaging time points, treatment plans, tumor volume, dose parameters, neurological function, KPS, CTCAE adverse events, causes of death, and more. This makes it suitable for building longitudinal prediction models, treatment-response evaluation models, or medical imaging AI research workflows. The project also mentions the NYUMets MONAI API, a MONAI extension for longitudinal oncology and imaging data, but the main text does not provide specific API examples, authentication methods, or performance benchmarks.

Pricing and Access

The main text does not disclose commercial pricing, subscription plans, or payment methods. The project is positioned as open data science and provides a Get Access entry point; it also mentions support from the AWS Open Data Initiative, nVidia, and others. However, the available information is insufficient to determine whether it is entirely free, whether an application is required, whether there is a data use agreement, or whether download limits apply.

Pros and Cons

Its strengths are a solid medical research background, detailed data structure, rich longitudinal dimensions, and relevance to the MONAI ecosystem, making it well suited to serious medical AI research. De-identification and randomized patient IDs also indicate basic privacy protection measures. The limitations are also clear: there is no description of ready-to-use AI models, no output quality metrics, and no information on dataset size, missingness, or annotation consistency. The page feels more like a data dictionary than a low-barrier product. For users without a medical or data science background, the learning curve is likely to be steep.

Who It’s For and Access from China

NYUMets is best suited for research teams in oncology, neurosurgery, radiation therapy, medical imaging AI, and real-world data studies, for use in research modeling, algorithm validation, and teaching. The main text does not mention access conditions from China, so network availability, account application requirements, and data download speeds are all unknown; payment information is also not disclosed. If access or application is restricted, alternatives worth considering include TCIA, IDC Imaging Data Commons, MONAI, and other public medical imaging datasets.